Kolexia
Laine Marc
Cardiologie
Hôpital Nord Marseille
Marseille, France
143 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Syndrome coronarien aigu Infarctus du myocarde Hémorragie Infarctus Maladie des artères coronaires Choc cardiogénique Défaillance cardiaque Choc Thrombose

Industries

Boston Scientific
11 collaboration(s)
Dernière en 2022
P\S\L Group Services
6 collaboration(s)
Dernière en 2023
A+A
4 collaboration(s)
Dernière en 2023
MSD
3 collaboration(s)
Dernière en 2022

Dernières activités

The PEERLESS II Study: PEERLESS II: RCT of FlowTriever vs. Anticoagulation Alone in Pulmonary Embolism
Essai Clinique (Inari Medical)   19 mars 2024
Rationale and design of the ULYSS trial: A randomized multicenter evaluation of the efficacy of early Impella CP implantation in acute coronary syndrome complicated by cardiogenic shock.
American heart journal   30 août 2023
Impact of targeted pulmonary arterial hypertension therapies in severe pulmonary hypertension in chronic lung diseases.
ERJ open research   21 août 2023
ULYSS: Evaluation of the Efficacy of Early Implantation of a Percutaneous Left Ventricular Assist Devices in Acute Coronary Syndrome Complicated by Cardiogenic Shock Compared to Conventional Therapy: a Prospective, Multicenter, Randomized, Controlled and Open-label Clinical Trial
Essai Clinique (Assistance publique - Hôpitaux de Marseille)   23 janvier 2023
Wearable cardioverter defibrillator: Bridge or alternative to implantation?
World journal of cardiology   08 avril 2022
-HH Gene Variants Encoding the Fc Gamma Receptor for the C-Reactive Protein Are Associated with Enhanced Monocyte CD32 Expression and Cardiovascular Events' Recurrence after Primary Acute Coronary Syndrome.
Biomedicines   19 février 2022
Haemodynamic support during high-risk percutaneous coronary intervention.
Archives of cardiovascular diseases   31 janvier 2022
Survival and Factors Associated with Survival with Extracorporeal Life Support During Cardiac Arrest: A Systematic Review and Meta-Analysis.
ASAIO journal (American Society for Artificial Internal Organs : 1992)   01 décembre 2021
A2 AR as a Novel Biomarkers for Physician Decision-making Improvement Evaluation's Patients With Suspected Acute Coronary Syndrome But Negative Troponin.: A 2A Receptor (A2 AR) as a Novel Biomarkers for Physician Decision-making Improvement Evaluation's Patients With Suspected Acute Coronary Syndrome But Negative Troponin.
Essai Clinique (Assistance publique - Hôpitaux de Marseille)   11 octobre 2021
Intensified immunosuppressive therapy in patients with immune checkpoint inhibitor-induced myocarditis.
Journal for immunotherapy of cancer   20 septembre 2021